Category :   No category

PRESENT QUESTIONS OF LUNG CANCER DIAGNOSIS AND TREATMENT
PRESENT QUESTIONS OF LUNG CANCER DIAGNOSIS AND TREATMENT
2019-04-04 3
PROTEOLYTIC DERIVATIVES OF PLASMINOGEN AS A FACTOR IN MALIGNANCY DEVELOPMENT
PROTEOLYTIC DERIVATIVES OF PLASMINOGEN AS A FACTOR IN MALIGNANCY DEVELOPMENT
2019-04-04 No views
TARGETED THERAPY IN NON-SMALL LUNG CANCER
TARGETED THERAPY IN NON-SMALL LUNG CANCER
2019-04-04 3
PERSPECTIVE OF CARBON NANOTUBES APPLICATION IN CANCER THERAPY
PERSPECTIVE OF CARBON NANOTUBES APPLICATION IN CANCER THERAPY
2019-04-04 4
ROLE OF MATRIX METALLOPROTEINASES (MMP) IN MALIGNANCIES. І. MMP CHARACTERISTICS, REGULATION, AND PROGNOSTIC VALUE
ROLE OF MATRIX METALLOPROTEINASES (MMP) IN MALIGNANCIES. І. MMP CHARACTERISTICS, REGULATION, AND PROGNOSTIC VALUE
2019-04-04 6
NEW CLASSIFICATION OF THE MYELODYSPLASTIC (PRELEUKAEMIAS) SYNDROMES
NEW CLASSIFICATION OF THE MYELODYSPLASTIC (PRELEUKAEMIAS) SYNDROMES
2019-04-04 2
THE ACTUAL ASPECTS OF THE MORPHOLOGICAL DIAGNOSTICS OF THE TUMORS OF CENTRAL NERVIOUS SYSTEM
THE ACTUAL ASPECTS OF THE MORPHOLOGICAL DIAGNOSTICS OF THE TUMORS OF CENTRAL NERVIOUS SYSTEM
2019-04-04 6
TNM CLASSIFICATION OF MALIGNANT TUMOURS: HISTORY, PRINCIPLES, PRACTICAL APPLICATION
TNM CLASSIFICATION OF MALIGNANT TUMOURS: HISTORY, PRINCIPLES, PRACTICAL APPLICATION
2019-04-04 1
INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
2019-04-04 4
BIOTHERAPY OF CANCER: ACHIEVEMENTS AND PERSPECTIVES
BIOTHERAPY OF CANCER: ACHIEVEMENTS AND PERSPECTIVES
2019-04-04 2
« ...678910...»
Publishing House “Akademperiodyka” Apteka online Компендиум — справочник лекарств №1 Chasopys online Oncology